Precision Medicine for Alzheimer's Disease Prevention.

Berkowitz, Cara L; Mosconi, Lisa; Scheyer, Olivia; Rahman, Aneela; Hristov, Hollie; Isaacson, Richard S

Berkowitz, Cara L; Mosconi, Lisa; Scheyer, Olivia; Rahman, Aneela; Hristov, Hollie; Isaacson, Richard S.

Afiliação

Berkowitz CL; Department of Neurology, Weill Cornell Medicine, New York, NY 10021, USA. cab2040@med.cornell.edu.
Mosconi L; Department of Neurology, Weill Cornell Medicine, New York, NY 10021, USA. lim2035@med.cornell.edu.
Scheyer O; Department of Neurology, Weill Cornell Medicine, New York, NY 10021, USA. ols2011@med.cornell.edu.
Rahman A; Department of Neurology, Weill Cornell Medicine, New York, NY 10021, USA. anr2781@med.cornell.edu.
Hristov H; Department of Neurology, Weill Cornell Medicine, New York, NY 10021, USA. how2005@med.cornell.edu.
Isaacson RS; Department of Neurology, Weill Cornell Medicine, New York, NY 10021, USA. rii9004@med.cornell.edu.

Healthcare (Basel) ; 6(3)2018 Jul 13.

Article em En | MEDLINE | ID: mdl-30011822

Palavras-chave

APOE; Alzheimer's disease prevention; MTHFR; apolipoprotein Îµ4; clinical precision medicine; methylenetetrahydrofolate reductase; precision medicine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Healthcare (Basel) Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google